Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$7.06 - $13.97 $219,128 - $433,600
-31,038 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$12.15 - $35.28 $8.05 Million - $23.4 Million
-662,749 Reduced 95.53%
31,038 $377,000
Q4 2021

Feb 11, 2022

SELL
$30.49 - $48.49 $9.59 Million - $15.2 Million
-314,388 Reduced 31.18%
693,787 $23.7 Million
Q3 2021

Nov 10, 2021

BUY
$41.66 - $52.52 $4.49 Million - $5.66 Million
107,851 Added 11.98%
1,008,175 $48.6 Million
Q2 2021

Aug 11, 2021

SELL
$36.62 - $51.69 $1.25 Million - $1.76 Million
-34,126 Reduced 3.65%
900,324 $40.7 Million
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $26.5 Million - $38.2 Million
-638,532 Reduced 40.59%
934,450 $45.3 Million
Q4 2020

Feb 12, 2021

SELL
$36.08 - $56.47 $723,367 - $1.13 Million
-20,049 Reduced 1.26%
1,572,982 $84.7 Million
Q3 2020

Nov 12, 2020

SELL
$33.26 - $40.48 $11.6 Million - $14.1 Million
-347,400 Reduced 17.9%
1,593,031 $58.7 Million
Q2 2020

Aug 12, 2020

SELL
$24.21 - $31.02 $13.7 Million - $17.6 Million
-566,351 Reduced 22.59%
1,940,431 $56.6 Million
Q1 2020

May 11, 2020

BUY
$20.5 - $34.53 $403,419 - $679,515
19,679 Added 0.79%
2,506,782 $69.2 Million
Q4 2019

Feb 07, 2020

SELL
$18.96 - $29.84 $3.94 Million - $6.2 Million
-207,837 Reduced 7.71%
2,487,103 $72.7 Million
Q3 2019

Nov 04, 2019

SELL
$19.12 - $26.24 $100,991 - $138,599
-5,282 Reduced 0.2%
2,694,940 $51.5 Million
Q2 2019

Aug 05, 2019

SELL
$19.57 - $24.1 $103,994 - $128,067
-5,314 Reduced 0.2%
2,700,222 $59.2 Million
Q1 2019

May 01, 2019

BUY
$12.14 - $20.46 $5.24 Million - $8.83 Million
431,393 Added 18.97%
2,705,536 $55.4 Million
Q4 2018

Feb 11, 2019

BUY
$11.24 - $18.5 $1.31 Million - $2.16 Million
116,717 Added 5.41%
2,274,143 $28.7 Million
Q3 2018

Nov 08, 2018

BUY
$12.5 - $15.38 $27 Million - $33.2 Million
2,157,426 New
2,157,426 $33.1 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.13B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.